• Report details
  • 15 Figures
  • 39 Tables
  • IBO’s 2025 Company of the Year
  • Thermo Fisher Aims to Improve Proteomics Software Workflows
    • MSAID
    • Proteinaceous
  • IBO Sales Indexes Report Growth Despite Mixed Results
    • Analytical Instrument Sales Index
      • Q4 CY25
      • CY25
    • Life Science Sales Index
      • Q4 CY25
      • CY25
    • End-Markets
      • Pharmaceuticals
      • Academia & Government
      • Industrial and Applied
    • Regional
      • China
      • Asia Pacific
      • Americas
      • Europe
    • Product Lines
      • Instruments
      • Recurring
    • Forecast
      • CY26
  • Correction: LabWare
  • Executive Briefing
    • Thermo Fisher Buys MS Software Firms
    • Alamar Files for IPO
    • HORIBA Chairman Survives Investor Challenge
    • Former Avantor CEO Joins PerkinElmer
    • StarLIMS to Expand to Offer Manufacturing Solutions
    • Mesa Labs Announces New CEO
    • Royston Instruments Buys Third Lab Equipment Company
  • Fourth Quarter Write-Ups: Bio-Rad Laboratories, Bruker, MilliporeSigma, Pacific…
    • Bio-Rad Posts a Slight Decrease in 2025
      • Q4
      • FYE
    • Bruker Forecasts a Challenging 2026 for BioSpin
      • Q4
      • FYE
    • MilliporeSigma Provides Quarterly Sales Details for New Business Segments
      • Q4
      • FYE
    • Pacific Biosciences Records Solid Clinical and Hospital Market Sales in 2025
      • Q4
      • FYE
    • Revvity Delivers a Solid Sales Performance in 2025
      • Q4
      • FYE
  • IBO Indexes Follow the US Stock Market’s Decline
    • Laboratory Instruments and Products Stock Index
      • Financial News
    • Diversified Instrumentation Stock Index
    • International Stocks
      • Asia
      • Europe
  • Market Profile: Fluorescence In Situ Hybridization (FISH)
    • Leading Vendors
    • Largest Markets
    • Cost of Kits and Probe Sets
  • Industry Watch
    • Government: NIH Grants Released According to Director
    • Biopharma: 2025 Shows Some Improvement in Fundraising
    • R&D: OECD Releases 2024 R&D Estimates
  • Region Watch
    • Middle East: Iran Conflict Sets Up Risks for Pharma
    • Canada: Private Sector Pharma R&D Spending Shows Robust Increase
    • Hong Kong: More Biotech Listings on the Way
  • News
    • Broad-Based Companies
      • Company Announcements
    • Surface Science
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Spectroscopy
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Lab Products
      • Lab Automation
      • Company Announcements
      • Product Introductions
      • Lab Equipment
      • Company Announcements
      • Product Introductions
  • Bottom Line
Instrument Business Outlook (v. 34, Iss. 24) - Company of the Year
2 Apr 2026

Request Access
 
Table of Contents
  • IBO’s 2025 Company of the Year
  • Thermo Fisher Aims to Improve Proteomics Software Workflows
    • MSAID
    • Proteinaceous
  • IBO Sales Indexes Report Growth Despite Mixed Results
    • Analytical Instrument Sales Index
      • Q4 CY25
      • CY25
    • Life Science Sales Index
      • Q4 CY25
      • CY25
    • End-Markets
      • Pharmaceuticals
      • Academia & Government
      • Industrial and Applied
    • Regional
      • China
      • Asia Pacific
      • Americas
      • Europe
    • Product Lines
      • Instruments
      • Recurring
    • Forecast
      • CY26
  • Correction: LabWare
  • Executive Briefing
    • Thermo Fisher Buys MS Software Firms
    • Alamar Files for IPO
    • HORIBA Chairman Survives Investor Challenge
    • Former Avantor CEO Joins PerkinElmer
    • StarLIMS to Expand to Offer Manufacturing Solutions
    • Mesa Labs Announces New CEO
    • Royston Instruments Buys Third Lab Equipment Company
  • Fourth Quarter Write-Ups: Bio-Rad Laboratories, Bruker, MilliporeSigma, Pacific Biosciences and Revvity
    • Bio-Rad Posts a Slight Decrease in 2025
      • Q4
      • FYE
    • Bruker Forecasts a Challenging 2026 for BioSpin
      • Q4
      • FYE
    • MilliporeSigma Provides Quarterly Sales Details for New Business Segments
      • Q4
      • FYE
    • Pacific Biosciences Records Solid Clinical and Hospital Market Sales in 2025
      • Q4
      • FYE
    • Revvity Delivers a Solid Sales Performance in 2025
      • Q4
      • FYE
  • IBO Indexes Follow the US Stock Market’s Decline
    • Laboratory Instruments and Products Stock Index
      • Financial News
    • Diversified Instrumentation Stock Index
    • International Stocks
      • Asia
      • Europe
  • Market Profile: Fluorescence In Situ Hybridization (FISH)
    • Leading Vendors
    • Largest Markets
    • Cost of Kits and Probe Sets
  • Industry Watch
    • Government: NIH Grants Released According to Director
    • Biopharma: 2025 Shows Some Improvement in Fundraising
    • R&D: OECD Releases 2024 R&D Estimates
  • Region Watch
    • Middle East: Iran Conflict Sets Up Risks for Pharma
    • Canada: Private Sector Pharma R&D Spending Shows Robust Increase
    • Hong Kong: More Biotech Listings on the Way
  • News
    • Broad-Based Companies
      • Company Announcements
    • Surface Science
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Spectroscopy
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Lab Products
      • Lab Automation
      • Company Announcements
      • Product Introductions
      • Lab Equipment
      • Company Announcements
      • Product Introductions
  • Bottom Line
Categories
To the Top
More information about this product